Wednesday, October 27, 2021

MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Announces Legal Efforts to Change MDO Stay on Bidi Sticks

 Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products by Bidi(R) Vapor LLC, has shared efforts being made to change a previously announced administrative stay on Bidi(R) Sticks. KAVL noted that Bidi Vapor LLC, the manufacturer of the premium Bidi Stick electronic nicotine delivery system (“ENDS”) has asked the FDA to reconsider its marketing denial order (“MDO”) for the Bidi Sticks. The company made this request based on the scientific evidence in its applications. Bidi Vapor is also requesting a judicial stay of the MDO with the 11th Circuit Court of Appeals. According to the announcement, the FDA issued an administrative stay of the MDO for the nontobacco-flavored BIDI Sticks pending its review of the company’s request that the MDO be rescinded. While it reviews the request, the FDA confirmed that Bidi Vapor’s flavored BIDI Sticks can remain on the market. In further action, last month Bidi Vapor filed a petition for review with the U.S. Court of Appeals for the Eleventh Circuit, asking the court to review the MDO under the Tobacco Control Act (“TCA”), the Administrative Procedure Act (“APA”) and the U.S. Constitution. The filing also includes a request to vacate the MDO and provide additional relief. “We appreciate FDA’s decision to stay, or put on hold, the MDO as it reconsiders its denial,” said Kaival Brands CEO Niraj Patel in the press release. “As we explained to the agency, Bidi Vapor submitted scientifically rigorous PMTAs that contained product-specific evidence demonstrating that the added benefit of our flavored BIDI Sticks to adult smokers outweighs any potential risks to youth, especially considering our stringent youth-access prevention measures and commitment to mature, adult-focused marketing. . . . That said, we are still seeking a formal, judicial stay from the appellate court pending the outcome of the lawsuit. We believe in science-based regulation of ENDS and hope the courts will require FDA to adhere to the law as it reviews our PMTAs.”

To view the full press release, visit https://ibn.fm/k0R3v

About Kaival Brands Innovations Group Inc.

Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor. For more information about the company, visit www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html